Buprenorphine/naloxone transmucosal - BioDelivery Sciences International

Drug Profile

Buprenorphine/naloxone transmucosal - BioDelivery Sciences International

Alternative Names: B-BNX; BEMA® Buprenorphine NX; BEMA® Buprenorphine/Naloxone; BNX; BUNAVAIL; Buprenorphine and naloxone buccal film; Buprenorphine/Naloxone buccal soluble film; Naloxone/buprenorphine - BioDelivery Sciences International; Naloxone/buprenorphine transmucosal - BioDelivery Sciences International

Latest Information Update: 16 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator BioDelivery Sciences International
  • Class Antidotes; Cyclopropanes; Drug withdrawal therapies; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists; Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Opioid abuse

Most Recent Events

  • 12 Oct 2017 BioDelivery Sciences settles litigation against Teva over ANDA submission in USA
  • 29 Aug 2017 Chemical structure information added
  • 02 May 2017 BioDelivery Sciences International withdraws prior to enrolment a phase III trial for Opioid abuse in USA (NCT02516436)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top